It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Liquid–liquid phase separation of proteins underpins the formation of membraneless compartments in living cells. Elucidating the molecular driving forces underlying protein phase transitions is therefore a key objective for understanding biological function and malfunction. Here we show that cellular proteins, which form condensates at low salt concentrations, including FUS, TDP-43, Brd4, Sox2, and Annexin A11, can reenter a phase-separated regime at high salt concentrations. By bringing together experiments and simulations, we demonstrate that this reentrant phase transition in the high-salt regime is driven by hydrophobic and non-ionic interactions, and is mechanistically distinct from the low-salt regime, where condensates are additionally stabilized by electrostatic forces. Our work thus sheds light on the cooperation of hydrophobic and non-ionic interactions as general driving forces in the condensation process, with important implications for aberrant function, druggability, and material properties of biomolecular condensates.
Elucidating the molecular driving forces underlying liquid–liquid phase separation is a key objective for understanding biological function and malfunction. Here the authors show that a wide range of cellular proteins, including FUS, TDP-43, Brd4, Sox2, and Annexin A11, which form condensates at low salt concentrations, can reenter a phase-separated regime at high salt concentrations.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details













1 University of Cambridge, Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
2 University of Cambridge, J J Thomson Avenue, Cavendish Laboratory, Department of Physics, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); University of Cambridge, Department of Genetics, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); University of Cambridge, Lensfield Road, Yusuf Hamied Department of Chemistry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
3 Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Dresden, Germany (GRID:grid.419537.d) (ISNI:0000 0001 2113 4567); Technische Universität Dresden, Tatzberg 47/49, Biotechnology Center (BIOTEC), Center for Molecular and Cellular Bioengineering (CMCB), Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257)
4 University of Cambridge, Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); Institute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka, Warsaw, Poland (GRID:grid.425290.8) (ISNI:0000 0004 0369 6111)
5 Technische Universität Dresden, Tatzberg 47/49, Biotechnology Center (BIOTEC), Center for Molecular and Cellular Bioengineering (CMCB), Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257)
6 University of Cambridge, Cambridge Institute for Medical Research, Department of Clinical Neurosciences, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
7 University of Cambridge, Cambridge Institute for Medical Research, Department of Clinical Neurosciences, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); University of Toronto and University Health Network, Division of Neurology, Department of Medicine, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938)
8 Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Dresden, Germany (GRID:grid.419537.d) (ISNI:0000 0001 2113 4567)
9 University of Cambridge, Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); University of Cambridge, J J Thomson Avenue, Cavendish Laboratory, Department of Physics, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)